Last reviewed · How we verify
Ulcerative colitis in remission
Approved treatments
- Rowasa · Meda Pharms
Rowasa works by blocking the production of prostaglandins, which are chemicals that cause inflammation in the rectum and colon. - MESA · Meda Pharms
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Ulcerative colitis in remission patent landscape — cliff calendar, originator estates, attackable patents
- Ulcerative colitis in remission treatment landscape brief
- Ulcerative colitis in remission treatment updates RSS
Frequently asked questions about Ulcerative colitis in remission
What drugs treat Ulcerative colitis in remission?
Tracked treatments include Rowasa, MESA.
What is the treatment for Ulcerative colitis in remission?
Standard treatment for Ulcerative colitis in remission includes Rowasa, MESA. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Ulcerative colitis in remission patent cliff · Ulcerative colitis in remission CI report
- Treatment: Rowasa · Meda Pharms
- Treatment: MESA · Meda Pharms
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing